RARA CRAFT DATABASE for FDA Medical Devices
510(k)K193155

FDA DEVICE FACTS

Nipro Dry Complete Dry Acid Concentrate for Hemodialysis

Nipro Renal Solutions USA, Corp.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATENovember 25, 2020PRODUCT CODEKPO

Indications for use

For DA-100 series:

This acid concentrate product is formulated for use in acute and chronic hemodialysis and to be used in conjunction with MedicaLyteTM bicarbonate, or an equivalent bicarbonate labeled for use in acute and chronic hemodialysis and having the same composition as MedicaLyteTM bicarbonate, in a 36.83X three-stream artificial kidney (hemodialysis) machine.

-or-

For DA-200 series:

This acid concentrate product is formulated for use in acute and chronic hemodialysis and to be used in conjunction with MedicaLyteTM bicarbonate, or an equivalent bicarbonate labeled for use in acute and chronic hemodialysis and having the same composition as MedicaLyteTM bicarbonate, in a 45X three-stream artificial kidney (hemodialysis) machine.

-or-

For DA-300 series:

This acid concentrate product is formulated for use in acute and chronic hemodialysis and to be used in conjunction with MedicaLyteTM bicarbonate, or an equivalent bicarbonate labeled for use in acute and chronic hemodialysis and having the same composition as MedicaLyteTM bicarbonate, in a 35X three-stream artificial kidney (hemodialysis) machine.

For DA-100 series: This acid concentrate product is formulated for use in acute and chronic hemodialysis and to be used in conjunction with MedicaLyte™ bicarbonate, or an equivalent bicarbonate labeled for use in acute and chronic hemodialysis and having the same composition as MedicaLyte ™ bicarbonate, in a 36.83X three-stream artificial kidney (hemodialysis) machine. -or- For DA-200 series: This acid concentrate product is formulated for use in acute and chronic hemodialysis and to be used in conjunction with MedicaLyte™ bicarbonate, or an equivalent bicarbonate labeled for

Nipro Renal Solutions Corporation USA Nipro Dry Complete™ Dry Acid Concentrate for Hemodialysis “Traditional” 510(k) Premarket Notification – K193155 510(K) SUMMARY UNDER 21 CFR 807.92 ________________________________________ 510(k) Premarket Notification for Nipro Renal Solutions Corporation USA K193155 – Nipro Dry Complete™ Dry Acid Concentrate for Hemodialysis Tab 5: Page 3 use in acute and chronic hemodialysis and having the same composition as MedicaLyte ™ bicarbonate, in a 45X three-stream artificial kidney (hemodialysis) machine. -or- For DA-300 series: This acid concentrate product is formulated for use in acute and chronic hemodialysis and to be used in conjunction with MedicaLyte™ bicarbonate, or an equivalent bicarbonate labeled for use in acute and chronic hemodialysis and having the same composition as MedicaLyte ™ bicarbonate, in a 35X three-stream artificial kidney (hemodialysis) machine.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026